Abstract
Background
The impact of various clinical variables on long-term survival of patients with acutely decompensated diastolic heart failure (DHF) compared to systolic heart failure (SHF) has not been sufficiently investigated.
Methods
Clinical, laboratory, electrocardiographic and echocardiographic data were collected and analyzed for all-cause mortality in 473 furosemide-treated patients aged ≥60 years, hospitalized for acutely decompensated HF.
Results
Diastolic heart failure patients (n = 183) were more likely to be older, female, hypertensive, obese, with shorter preexisting HF duration, atrial fibrillation, lower New York Heart Association (NYHA) class, lower maintenance furosemide dosages, and to receive calcium antagonists. The SHF group (290 patients) demonstrated prevailing coronary artery disease, nitrate or digoxin treatment, and electrocardiographic conduction disturbances (P ≤ 0.01 in all comparisons). On median 35-month follow-up, the respective one-, three- and five-year survival rates were 82%, 48% and 33% in DHF versus 74%, 46% and 30% in SHF (P = 0.3). Higher furosemide daily dosage at discharge (OR = 1.24, 95% CI = 1.11–1.37, P < 0.001), increasing age (OR = 1.29, 95% CI = 1.09–1.54, P = 0.003), peripheral arterial disease (OR = 1.47, 95% CI = 1.02–2.13, P = 0.043), and a history of stroke (OR = 1.44, 95% CI = 0.98–2.1, P = 0.066) were most significantly associated with shorter survival in SHF. DHF, in turn, demonstrated higher NYHA class (OR = 2.52, 95% CI = 1.48–4.29, P < 0.001), history of non-advanced malignancy (OR = 2.51, 95% CI = 1.3–4.85, P = 0.012), and atrial fibrillation (OR = 1.6, 95% CI = 0.97–2.64, P = 0.066). Antilipid treatment (OR = 0.56, 95% CI = 0.3–1.02, P = 0.049) predicted better survival.
Conclusion
In-patients with acutely decompensated DHF differ from similar SHF subjects with respect to prognostic significance of a number of clinical variables. This observation might carry practical implications.
Similar content being viewed by others
References
Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF Jr, Gheorghiade M (2006) Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114:397–403
Angermann C, Hoyer C, Ertl G (2006) Differential diagnosis of dyspnea–significance of clinic aspects, imaging and biomarkers for the diagnosis of heart failure. Clin Res Cardiol 95(Suppl 4): 57–70
Aurigemma GP, Gaasch WH (2004) Diastolic heart failure. N Engl J Med 351:1097–1105
Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:260–269
Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216
Cahill JM, Ryan E, Travers B, Ryder M, Ledwidge M, McDonald K (2006) Progression of preserved systolic function heart failure to systolic dysfunction: a natural history study. Int J Cardiol 106:95–102
Chatterjee K, Massie B (2007) Systolic and diastolic heart failure: differences and similarities. J Cardiac Fail 13:569–576
Dixon WJ (1993) BMDP Statistical Software. University of California Press, Los-Angeles
Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW (2000) The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35:681–689
Dubourg O, Gueret P, Beauchet A, Nisse-Durgeat S, Ducardonnet A (2008) Focale: study of systolic and diastolic heart failure in a French elderly population. Int J Cardiol 124:188–192
Düngen HD, Apostolović S, Inkrot S, Tahirović E, Krackhardt F, Pavlović M, Putniković B, Lainščak M, Gelbrich G, Edelmann F, Wachter R, Eschenhagen T, Waagstein F, Follath F, Rauchhaus M, Haverkamp W, Osterziel KJ, Dietz R (2008) Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. Clin Res Cardiol 97:578–586
Eshaghian S, Horwich TB, Fonarow GC (2006) Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 97:1759–1764
Fukuta H, Sane DC, Brucks S, Little WC (2005) Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 112:357–363
Gottlieb SS, Baruch L, Kukin ML, Bernstein JL, Fisher ML, Packer M (1990) Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 16:827–831
Gustafsson F, Torp-Pedersen C, Brendorp B, Seibaek M, Burchardt H, Kobel L; DIAMOND Study Group (2003) Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 24:863–870
Hettwer S, Panzner-Grote B, Witthaut R, Werdan K (2007) Isolated diastolic dysfunction – diagnostic value of tissue Doppler imaging, colour M-mode and N-terminal pro B-type natriuretic peptide. Clin Res Cardiol 96:874–882
Hogg K, Swedberg K, McMurray J (2004) Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43:317–327
Ilksoy N, Hoffman M, Moore RH, Easley K, Jacobson TA (2006) Comparison of African-American patients with systolic heart failure versus preserved ejection fraction. Am J Cardiol 98:806–808
Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP (2002) Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288:2144–2150
Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV (2003) Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290:2581–2587
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254
Lewis BS, Shotan A, Gottlieb S, Behar S, Halon DA, Boyko V, Leor J, Grossman E, Zimlichman R, Porath A, Mittelman M, Caspi A, Garty M (2007) Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure Survey. IMAJ 9:234–238
Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin D, Krumholz HM (2003) Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41:217–223
McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251–259
Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550
Pernenkil R, Vinson JM, Shah AS, Beckham V, Wittenberg C, Rich MW (1997) Course and prognosis in patients ≥ 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 79:216–219
Philbin EF, Rocco TA Jr, Lindenmuth NW, Ulrich K, Jenkins PL (2000) Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 109:605–613
Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM (2003) Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41:1510–1518
Varadarajan P, Pai RG (2003) Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. J Card Fail 9:107–112
Varela-Roman A, Grigorian L, Barge E, Bassante P, de la Pena MG, Gonzalez-Juanatey JR (2005) Heart failure in patients with preserved and deteriorated left ventricular ejection fraction. Heart 91:489–494
Vasan RS, Levy D (2000) Defining diastolic heart failure: A call for standardized diagnostic criteria. Circulation 101:2118–2121
Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47:76–84
Zile MR, Baicu CF, Bonnema DD (2005) Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis 47: 307–313
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gorelik, O., Almoznino-Sarafian, D., Shteinshnaider, M. et al. Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure. Clin Res Cardiol 98, 224–232 (2009). https://doi.org/10.1007/s00392-009-0746-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-009-0746-1